getting world vaccinated covid-19 matter life death involving complicated scientific processes multinational corporations government promises backroom deals figuring world vaccine not easy agathe demarais director global forecasting economist intelligence unit comprehensive research topic looked world production capacity healthcare facilities needed vaccines people arms number people country contend afford findings fall predictable lines rich v poor uk supplied vaccines right afford invest lot money vaccine development queue rich countries not like canada eu bloc little canada criticized end year buying times supply needs cover population not positioned priority delivery partly country decided invest vaccines european factories afraid donald trump issue export